{"id":5571,"date":"2023-12-04T05:44:28","date_gmt":"2023-12-04T11:44:28","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5571"},"modified":"2025-06-27T11:27:04","modified_gmt":"2025-06-27T16:27:04","slug":"glenn-sblendorio-as-chairman-of-the-board","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/","title":{"rendered":"Nanoscope Therapeutics \u306f\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u306e\u6210\u9577\u3092\u7d99\u7d9a\u3002\u8ca1\u52d9\u304a\u3088\u3073\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u306e\u5206\u91ce\u3067\u5b9f\u7e3e\u306e\u3042\u308b\u30ea\u30fc\u30c0\u30fc\u3001\u30b0\u30ec\u30f3\u30fb\u30b9\u30d6\u30ec\u30f3\u30c9\u30ea\u30aa\u6c0f\u3092\u53d6\u7de0\u5f79\u4f1a\u9577\u306b\u8fce\u3048\u308b"},"content":{"rendered":"
\n
\n

<\/h1>\n

\u65b0\u305f\u306a\u53d6\u308a\u7d44\u307f\u306f\u3001\u7d44\u7e54\u306e\u6226\u7565\u7684\u65b9\u5411\u6027\u306e\u7d99\u7d9a\u7684\u306a\u5f37\u5316\u3092\u5f37\u8abf\u3059\u308b\u3082\u306e\u3067\u3059\u3002<\/em><\/h3>\n<\/div>\n<\/div>\n
\n
\n
\n
\n

\u30c6\u30ad\u30b5\u30b9\u5dde\u30c0\u30e9\u30b9 \u2013 2023 \u5e74 12 \u6708 4 \u65e5 \u2013<\/strong> \u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u3092\u958b\u767a\u3059\u308b\u81e8\u5e8a\u6bb5\u968e\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\uff08\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\uff09\u306f\u672c\u65e5\u3001\u30b0\u30ec\u30f3\u30fb\u30b9\u30d6\u30ec\u30f3\u30c9\u30ea\u30aa\u6c0f\u3092\u53d6\u7de0\u5f79\u4f1a\u9577\u306b\u4efb\u547d\u3057\u3001\u5373\u6642\u767a\u52b9\u3059\u308b\u3053\u3068\u3092\u767a\u8868\u3057\u305f\u3002\u773c\u79d1\u696d\u754c\u306b\u304a\u3051\u308b\u5e83\u7bc4\u306a\u7d4c\u55b6\u9663\u306e\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3092\u7279\u5fb4\u3068\u3059\u308b 30 \u5e74\u4ee5\u4e0a\u306e\u6a21\u7bc4\u7684\u306a\u7d4c\u9a13\u3092\u6301\u3064 Sblendrio \u6c0f\u306f\u3001Nanscope \u306e\u6226\u7565\u7684\u30d3\u30b8\u30e7\u30f3\u306e\u9054\u6210\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u307e\u3059\u3002<\/p>\n

\u30b9\u30d6\u30ec\u30f3\u30c9\u30ea\u30aa\u6c0f\u306f\u53d6\u7de0\u5f79\u4f1a\u9577\u3068\u3057\u3066\u306e\u65b0\u305f\u306a\u5f79\u5272\u306b\u304a\u3044\u3066\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u7d44\u7e54\u6226\u7565\u3068\u65b9\u5411\u6027\u3092\u5b9f\u884c\u3059\u308b\u4e0a\u3067\u53d6\u7de0\u5f79\u4f1a\u306e\u5b9f\u52b9\u6027\u3092\u78ba\u4fdd\u3059\u308b\u4e0a\u3067\u6975\u3081\u3066\u91cd\u8981\u306a\u5f79\u5272\u3092\u679c\u305f\u3059\u3053\u3068\u306b\u306a\u308b\u3002\u8ca1\u52d9\u3068\u4e8b\u696d\u958b\u767a\u306b\u5bfe\u3059\u308b\u5f7c\u306e\u5305\u62ec\u7684\u306a\u7406\u89e3\u306f\u3001\u73fe\u5728\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u82e6\u3057\u3080\u4f55\u767e\u4e07\u4eba\u3082\u306e\u4eba\u3005\u306b\u65b0\u305f\u306a\u8996\u529b\u3078\u306e\u5e0c\u671b\u3092\u3082\u305f\u3089\u3059\u3068\u3044\u3046\u4f7f\u547d\u3092\u9054\u6210\u3059\u308b\u305f\u3081\u306b\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u3092\u5c0e\u304f\u306e\u306b\u5f79\u7acb\u3064\u3067\u3057\u3087\u3046\u3002<\/p>\n

\u30b9\u30d6\u30ec\u30f3\u30c9\u30ea\u30aa\u6c0f\u306f\u4eca\u56de\u306e\u5c31\u4efb\u306b\u3064\u3044\u3066\u3001\u300c\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u53d6\u7de0\u5f79\u4f1a\u9577\u306b\u5c31\u4efb\u3067\u304d\u308b\u3053\u3068\u3092\u5149\u6804\u306b\u601d\u3044\u307e\u3059\u3002\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u9769\u65b0\u7684\u306a\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u306b\u53d6\u308a\u7d44\u3080\u540c\u793e\u306e\u59ff\u52e2\u306f\u3001\u7db2\u819c\u5206\u91ce\u3067\u610f\u7fa9\u306e\u3042\u308b\u8ca2\u732e\u3092\u3057\u305f\u3044\u3068\u3044\u3046\u79c1\u306e\u60c5\u71b1\u3068\u5408\u81f4\u3057\u3066\u3044\u307e\u3059\u3002\u53d6\u7de0\u5f79\u4f1a\u304a\u3088\u3073\u7d4c\u55b6\u9663\u3068\u5354\u529b\u3057\u3066\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u63a8\u9032\u3057\u3001\u5171\u901a\u306e\u4f7f\u547d\u306e\u5b9f\u73fe\u306b\u8ca2\u732e\u3067\u304d\u308b\u3053\u3068\u3092\u697d\u3057\u307f\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u300d\u3068\u8ff0\u3079\u307e\u3057\u305f\u3002\u201c<\/p>\n

\u3054\u304f\u6700\u8fd1\u3067\u306f\u3001\u30b9\u30d6\u30ec\u30f3\u30c9\u30ea\u30aa\u6c0f\u306f\u3001\u30a2\u30b9\u30c6\u30e9\u30b9\u88fd\u85ac\u306e IVERIC bio, Inc. (\u65e7 Ophthotech Corporation) \u3067\u3001CEO\u3001\u793e\u9577\u3001\u53d6\u7de0\u5f79\u306a\u3069\u3001\u3055\u307e\u3056\u307e\u306a\u91cd\u8981\u306a\u6307\u5c0e\u7684\u5f79\u5272\u3092\u6b74\u4efb\u3057\u307e\u3057\u305f\u3002\u307e\u305f\u3001EVP\u3001COO\u3001CFO\u3001\u8ca1\u52d9\u62c5\u5f53\u3082\u52d9\u3081\u307e\u3057\u305f\u3002\u3055\u3089\u306b\u3001The Medicines Company \u3067\u306f\u793e\u9577\u3001CFO\u3001\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3092\u52d9\u3081\u3001Eyetech Pharmaceuticals \u3067\u306f EVP \u304a\u3088\u3073 CFO \u3092\u52d9\u3081\u307e\u3057\u305f\u3002\u30b9\u30d6\u30ec\u30f3\u30c9\u30ea\u30aa\u6c0f\u306f\u3001\u30ad\u30e3\u30ea\u30a2\u306e\u521d\u671f\u306b\u306f MPM Capital Advisors, LLC \u306e\u30de\u30cd\u30fc\u30b8\u30f3\u30b0 \u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3092\u52d9\u3081\u3001\u30db\u30d5\u30de\u30f3 \u30e9 \u30ed\u30c3\u30b7\u30e5\u3067\u3055\u307e\u3056\u307e\u306a\u4e0a\u7d1a\u8ca1\u52d9\u8077\u3092\u6b74\u4efb\u3057\u307e\u3057\u305f\u3002<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306eCEO\u517c\u5171\u540c\u5275\u8a2d\u8005\u3067\u3042\u308b\u30b9\u30e9\u30ac\u30ca\u30fb\u30d0\u30c3\u30bf\u30c1\u30e3\u30ea\u30e4\u6c0f\u306f\u3001\u4eca\u56de\u306e\u4efb\u547d\u306b\u3064\u3044\u3066\u6b21\u306e\u3088\u3046\u306b\u559c\u3073\u3092\u8868\u660e\u3057\u307e\u3057\u305f\u3002\u300c\u30b0\u30ec\u30f3\u30fb\u30b9\u30d6\u30ec\u30f3\u30c9\u30ea\u30aa\u6c0f\u3092\u53d6\u7de0\u5f79\u4f1a\u9577\u3068\u3057\u3066\u8fce\u3048\u308b\u3053\u3068\u304c\u3067\u304d\u3001\u5927\u5909\u5b09\u3057\u304f\u601d\u3044\u307e\u3059\u3002\u9769\u65b0\u7684\u306a\u4f01\u696d\u3092\u69cb\u7bc9\u30fb\u62e1\u5927\u3057\u3066\u304d\u305f\u8c4a\u5bcc\u306a\u7d4c\u9a13\u3068\u3001\u7db2\u819c\u6cbb\u7642\u85ac\u3092\u5e02\u5834\u306b\u6295\u5165\u3057\u3066\u304d\u305f\u78ba\u304b\u306a\u77e5\u8b58\u306f\u3001\u773c\u79d1\u696d\u754c\u306b\u304a\u3051\u308b\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u30ea\u30fc\u30c0\u30fc\u3068\u3057\u3066\u306e\u5730\u4f4d\u3092\u9593\u9055\u3044\u306a\u304f\u5f37\u5316\u3057\u3066\u304f\u308c\u308b\u3067\u3057\u3087\u3046\u3002\u4eca\u5f8c\u306e\u767a\u5c55\u6bb5\u968e\u306b\u304a\u3044\u3066\u3001\u5f7c\u306e\u5c02\u9580\u77e5\u8b58\u3092\u6700\u5927\u9650\u306b\u6d3b\u7528\u3067\u304d\u308b\u3053\u3068\u3092\u697d\u3057\u307f\u306b\u3057\u3066\u3044\u307e\u3059\u3002\u300d\u201c<\/p>\n

\u30b9\u30d6\u30ec\u30f3\u30c9\u30ea\u30aa\u6c0f\u306f\u3001\u5f53\u793e\u306b\u3068\u3063\u3066\u6975\u3081\u3066\u91cd\u8981\u306a\u6642\u671f\u306b\u5165\u793e\u3057\u307e\u3057\u305f\u3002\u4eca\u56de\u306e\u4efb\u547d\u306f\u3001\u591a\u69d8\u3067\u6709\u80fd\u306a\u30a2\u30c9\u30d0\u30a4\u30b6\u30fc\u9663\u3092\u7d50\u96c6\u3057\u3001\u7d44\u7e54\u306e\u9769\u65b0\u3068\u6210\u529f\u3092\u63a8\u9032\u3059\u308b\u3053\u3068\u3067\u3001\u53d6\u7de0\u5f79\u4f1a\u306e\u5f71\u97ff\u529b\u3092\u6700\u5927\u9650\u306b\u9ad8\u3081\u308b\u3068\u3044\u3046\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306e\u53d6\u308a\u7d44\u307f\u3092\u53cd\u6620\u3057\u305f\u3082\u306e\u3067\u3059\u3002\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306f\u3001\u60a3\u8005\u3068\u533b\u5e2b\u306b\u6c38\u7d9a\u7684\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u308b\u9769\u65b0\u7684\u306a\u7db2\u819c\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u958b\u767a\u306b\u5c3d\u529b\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>\n

\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u306b\u3064\u3044\u3066
\n<\/strong>www.nanostherapeutics.com<\/a>
\n<\/strong>Nanoscope Therapeutics \u306f\u3001\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u907a\u4f1d\u6027\u7db2\u819c\u75be\u60a3\u306b\u3088\u3063\u3066\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u305b\u305a\u8996\u529b\u3092\u56de\u5fa9\u3059\u308b\u5149\u907a\u4f1d\u5b66\u7684\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u540c\u793e\u306e\u4e3b\u529b\u8cc7\u7523\u3067\u3042\u308b MCO-010 \u306f\u3001\u7c73\u56fd\u3067\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3092\u5bfe\u8c61\u3068\u3057\u305f RESTORE \u7b2c 2b \u76f8\u591a\u65bd\u8a2d\u7121\u4f5c\u70ba\u5316\u4e8c\u91cd\u30de\u30b9\u30af\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u7d50\u679c\u3092\u6700\u8fd1\u5831\u544a\u3057\u307e\u3057\u305f\u3002\u00a0(NCT04945772)<\/a>\u3002\u540c\u793e\u306f\u6700\u8fd1\u3001\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3082\u5b8c\u4e86\u3057\u305f\u3002\u00a0(NCT05417126)<\/a>\u3002 MCO-010\u306f\u3001\u7db2\u819c\u8272\u7d20\u5909\u6027\u75c7\u3068\u30b7\u30e5\u30bf\u30eb\u30ac\u30eb\u30c8\u306e\u4e21\u65b9\u306b\u5bfe\u3057\u3066FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u304a\u3088\u3073FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u8cc7\u7523\u306b\u306f\u3001\u5730\u7406\u7684\u840e\u7e2e\u306b\u5bfe\u3059\u308b\u975e\u30a6\u30a4\u30eb\u30b9\u30ec\u30fc\u30b6\u30fc\u306b\u3088\u308b MCO-020 \u907a\u4f1d\u5b50\u6cbb\u7642\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n

\u30e1\u30c7\u30a3\u30a2\u306e\u304a\u554f\u3044\u5408\u308f\u305b\u306f\u4ee5\u4e0b\u307e\u3067\u3054\u9023\u7d61\u304f\u3060\u3055\u3044\u3002<\/strong>
\n\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba
\n212-600-1902
\nPR@nanostherapeutics.com<\/a><\/p>\n<\/div>\n<\/div>\n<\/section>\n<\/article>","protected":false},"excerpt":{"rendered":"

New Addition Highlights Continued Enhancement of Organization\u2019s Strategic Trajector Dallas, TX \u2013 December 4, 2023 \u2013 Nanoscope Therapeutics (Nanoscope), a clinical-stage biotechnology company developing gene therapies for inherited retinal diseases, today announced the appointment of Glenn Sblendorio as Chairman of the Board, effective immediately. With more than 30 years of exemplary experience marked by extensive executive leadership in the ophthalmic industry, Mr. Sblendorio will support Nanoscope in reaching its strategic vision. In his new role as Chairman of the Board, Mr. Sblendorio will play a pivotal role in ensuring the effectiveness of the board of directors in implementing Nanoscope\u2019s organizational strategy and direction. His comprehensive understanding of finance and business […]<\/p>\n","protected":false},"author":6,"featured_media":5573,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5571","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"\nNanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2023-12-04T11:44:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T16:27:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board\",\"datePublished\":\"2023-12-04T11:44:28+00:00\",\"dateModified\":\"2025-06-27T16:27:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/\"},\"wordCount\":547,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/NSCOPE_LI_Sblendorio1.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/\",\"name\":\"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/NSCOPE_LI_Sblendorio1.jpg\",\"datePublished\":\"2023-12-04T11:44:28+00:00\",\"dateModified\":\"2025-06-27T16:27:04+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/NSCOPE_LI_Sblendorio1.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/NSCOPE_LI_Sblendorio1.jpg\",\"width\":1200,\"height\":800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2023\\\/12\\\/04\\\/glenn-sblendorio-as-chairman-of-the-board\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u7d4c\u55b6\u9663\u306e\u5f37\u5316\u3092\u7d99\u7d9a\u3002\u91d1\u878d\u3068\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u3067\u5b9f\u7e3e\u306e\u3042\u308b\u30ea\u30fc\u30c0\u30fc\u3001\u30b0\u30ec\u30f3\u30fb\u30b9\u30d6\u30ec\u30f3\u30c9\u30ea\u30aa\u6c0f\u3092\u4f1a\u9577\u3068\u3057\u3066\u8fce\u3048\u5165\u308c\u308b - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2023-12-04T11:44:28+00:00","article_modified_time":"2025-06-27T16:27:04+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"3\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board","datePublished":"2023-12-04T11:44:28+00:00","dateModified":"2025-06-27T16:27:04+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/"},"wordCount":547,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/","url":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u7d4c\u55b6\u9663\u306e\u5f37\u5316\u3092\u7d99\u7d9a\u3002\u91d1\u878d\u3068\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u3067\u5b9f\u7e3e\u306e\u3042\u308b\u30ea\u30fc\u30c0\u30fc\u3001\u30b0\u30ec\u30f3\u30fb\u30b9\u30d6\u30ec\u30f3\u30c9\u30ea\u30aa\u6c0f\u3092\u4f1a\u9577\u3068\u3057\u3066\u8fce\u3048\u5165\u308c\u308b - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","datePublished":"2023-12-04T11:44:28+00:00","dateModified":"2025-06-27T16:27:04+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2023\/12\/NSCOPE_LI_Sblendorio1.jpg","width":1200,"height":800},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2023\/12\/04\/glenn-sblendorio-as-chairman-of-the-board\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics Continues Leadership Growth; Welcomes Accomplished Finance and Biotech Leader Glenn Sblendorio as Chairman of the Board"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5571","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5571"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5571\/revisions"}],"predecessor-version":[{"id":9060,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5571\/revisions\/9060"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5573"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5571"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5571"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5571"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}